Part 2 INTELLIGENT MEDICINE: Gut Health Innovations: Insights from Martha Carlin
by Kevin Danielson September 16, 2025
Martha Carlin, CEO and founder of the Bio Collective, details the significant influence of the microbiome on overall health. Martha discusses her unconventional path from accounting to microbiome research, sparked by her husband’s Parkinson’s diagnosis. Together, they explore the complex connections between gut health and diseases like Parkinson’s, autism, and even Alzheimer’s. Martha sheds light on groundbreaking research funded by NIH grants, the potential of machine learning and AI in understanding microbiome patterns, and the future prospects of personalized probiotics. Practical advice on maintaining a healthy microbiome, the impact of diet and exercise, and the intriguing intersections between gut health, neurochemistry, and systemic diseases are highlighted. The discussion also covers challenges in integrating microbiome research into clinical practice and potential future therapies.
Behind closed eyes, the brain is carrying out a carefully coordinated night shift. And research into the microbiome raises an intriguing question: how might the activity in our gut influence the sleep that gives this work its opportunity?
When discussing gut health, the conversation usually centers on the microbiome. While balancing gut bacteria remains essential, cutting-edge science highlights another critical component of cellular health: the glycocalyx.
When discussing chronic neurological conditions like Parkinson’s disease, conventional medicine frequently focuses on a single narrative: dopamine depletion. While managing neurotransmitters remains a core part of traditional care, emerging physical chemistry and microbiome research reveal a far broader picture.